NT

Nitin Tandon

Active Director Director DIN 03624828
DIN 03624828 First appointment Oct 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2011
Shareholding value •••• Premium profile

About Nitin Tandon

Data last updated:

Nitin Tandon is a Director at Santo Medi Sciences Private Limited (since 2011). The company operates in Pharma. Santo Medi Sciences Private Limited reported revenue of ₹5.27 Cr (FY 2024).

DIN 03624828
Primary Designation Director
Industry Pharma
First Appointment 01 Oct 2011
Oldest Company Age 16 yrs
Largest company Santo Medi Sciences Private Limited · ₹5.27 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Santo Medi Sciences Private Limited U93000UP2010PTC042054
Director01 Oct 20112010₹5.27 Cr (FY 2024)Active

Board colleagues of Nitin Tandon

Directorship timeline

Open interactive timeline →
Santo Medi Sciences Private Limited
Premium access

Shareholding and investment profile for Nitin Tandon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Tandon

Nitin Tandon currently holds 1 directorship: Santo Medi Sciences Private Limited (Director, since 01 Oct 2011, revenue ₹5.27 Cr (FY 2024)).

Nitin Tandon was first appointed on 01 Oct 2011 as Director at Santo Medi Sciences Private Limited.

The current boards of Nitin Tandon's companies include Rajani Tandon (Santo Medi Sciences Private Limited), Shivani Tandon (Santo Medi Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available